🔴 ADMA is trading 5% down today as class-action lawsuit notices resurface

ADMA is trading 5.09% down at $8.30 after fresh class-action lawsuit notices resurfaced against the company.

• Investor law firm coverage on June 29 highlighted the filing against ADMA Biologics, acting as the primary catalyst for the downward pressure.
• The move appears company-specific, as ADMA is underperforming while broader market indices trend higher.